Improving Drug Safety-Reference-Cited by-同舟云学术

Improving Drug Safety

Published:2009-06 Issue:3 Volume:23 Page:127-130
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

McClure David L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF03256760.pdf

Reference20 articles.

1. Härmark L, van Grootheest AC. Pharmacovigilance: methods, recent developments and future prospects. Eur. J Clin Pharmacol 2008; 64: 743–52

2. Strom BL. How the US drug safety system should be changed. JAMA 2006; 295 (17): 2072–5

3. Arlett P, Moseley J, Seligman PJ. A view from regulatory agencies. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. Sussex: John Wiley & Sons, 2005

4. Fletcher AP. Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J R Soc Med 1991; 84: 341–4

5. Goldman SA. Limitations and strengths of spontaneous reports data. Clin Ther 1998; 20 Suppl. C: C40–4

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards robust pharmacovigilance surveillance systems;Open Health;2024-01-01

2. A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital;Journal of Basic and Clinical Physiology and Pharmacology;2014-01-01

3. Gathering and Exploring Scientific Knowledge in Pharmacovigilance;PLoS ONE;2013-12-11

4. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools;Pharmacoepidemiology and Drug Safety;2012-12-04

5. Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants;Expert Opinion on Drug Safety;2012-02-08